Velscope Presentation (Short)
-
Upload
parag-agarwal -
Category
Health & Medicine
-
view
473 -
download
2
Transcript of Velscope Presentation (Short)
3
DETECT THE EARLIEST CHANGES
7Image courtesy of the British Columbia Oral Cancer Prevention Program
Patient DPatient D
Abnormal Tissue?
8Images courtesy of the British Columbia Oral Cancer Prevention Program
Patient DPatient D
Clinical Appearance
Irregular, Dark Area
Biopsy confirmed Carcinoma in situ
9Image courtesy of the British Columbia Oral Cancer Prevention Program
Patient EPatient E
Where Is The Abnormal Tissue?
Polyp
10
Mild dysplasia
CIS
Clinical Appearance
Suspicious region is now clearly visible. Confirmed CIS.
Polyp
Images courtesy of the British Columbia Oral Cancer Prevention Program
Patient EPatient E (continued)(continued)
Polyp(white)
11
Oral Lesions May Show as
Irregular, Dark Areas
Images courtesy of the British Columbia Oral Cancer Prevention Program
Observe or Refer?
Severe Dysplasia
12
An Oral Lesion that Shows No Change in Autofluorescence
Appearing Pale Green
Images courtesy of the British Columbia Oral Cancer Prevention Program
Hyperplasia
Observe or Refer?
14
Pre-clinical discovery
Left palate : low-grade mucoepidermoid carcinoma
15
EXTENSIVE CLINICAL SUPPORT
10+ Years of Research in the Oral Cavity
• 2009 General Dentistry – K. Huff, et al• 2007 Head & Neck – P.M. Williams, et al.• 2006 Clinical Cancer Research – C.F. Poh, et al• 2005 Oral Oncology – deVeld, et al.
Proven Efficacywww.VELscope.com/research
16
Reimbursement Code (US)
D0431
Adjunctive Mucosal ScreeningAdjunctive Mucosal ScreeningAn adjunctive pre-diagnostic test
that aids in detection of mucosal abnormalities including
pre-malignant and malignant lesions.Not to include cytology or biopsy.
Note: This reimbursement code is only valid in the U.S. and it will be different for other countries.